Mithu Maheswaranathan, MDRheumatoid Arthritis | September 7, 2023
A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort.
Read More
Patrick DalyRheumatoid Arthritis | July 26, 2023
Abatacept improved outcomes for rheumatoid arthritis refractory to methotrexate or TNFi versus rituximab or tocilizumab.
Mithu Maheswaranathan, MDRheumatoid Arthritis | July 26, 2023
Ultra-low dose rituximab significantly reduced the rate of infections versus the standard low dosage in rheumatoid arthritis.
Rebecca AraujoRheumatology | July 17, 2023
Individuals with systemic lupus erythematosus face a substantial economic burden in the first 12 months following treatment.
Mithu Maheswaranathan, MDRheumatology | June 29, 2023
Researchers examined changes in objective measures of cardiorespiratory function and patient-reported outcomes in lupus.
Mithu Maheswaranathan, MDRheumatology | June 20, 2023
A study sought to characterize racial differences in lupus clinical manifestations.
Rebecca AraujoRheumatoid Arthritis | June 5, 2023
The American College of Rheumatology has released new recommendations for the management of rheumatoid arthritis.
Rebecca AraujoRheumatology | June 2, 2023
A study reported an increased psychiatric morbidity burden in patients with juvenile idiopathic arthritis.
Patrick DalyRheumatoid Arthritis | May 30, 2023
Patients with rheumatoid arthritis with lower hemoglobin levels may be more likely to have increased progression over time.
Patrick DalyRheumatoid Arthritis | May 16, 2023
Researchers established tranexamic acid was safe and effective in patients with rheumatoid arthritis following TKA.
Rob DillardOsteoporosis | May 8, 2023
The use of anabolic agents for the treatment of osteoporosis is not linked with increased risk of primary bone malignancy.
Rebecca AraujoRheumatology | April 26, 2023
New data from a study funded by the National Institutes of Health reported that children with multisystem inflammatory ...
Patrick DalyRheumatoid Arthritis | April 20, 2023
In a recent study, published in Rheumatology International, researchers sought to determine predictive variables for ...
Rebecca AraujoRheumatology | April 17, 2023
A randomized, placebo-controlled clinical trial did not find a significant clinical benefit of colchicine twice daily ...
Rebecca AraujoRheumatology | April 13, 2023
Different biological immunotherapies for the treatment of psoriasis are associated with variable delays in progression ...
Patrick DalyRheumatoid Arthritis | April 11, 2023
Telomere length shortening plays a role in the deterioration and death of various immune cells, leading to immune ...
Rob DillardPsoriatic Arthritis | April 6, 2023
Soumya Chakravarty, MD, PhD, FACP, FACR, Senior Director, Strategic Lead, Rheumatology Therapeutic Area at The Janssen ...
Mithu Maheswaranathan, MDPulmonology | April 3, 2023
A new study published in JAMA Network Open suggests patients with granulomatosis with polyangiitis (GPA) are more likely ...
Rebecca AraujoRheumatology | March 30, 2023
Decreasing body mass index (BMI) was independently associated to reduced progression of knee osteoarthritis (OA) on ...
Patrick DalyRheumatoid Arthritis | March 29, 2023
In the phase 4 AWARE study, researchers compared golimumab and infliximab in patients with rheumatoid arthritis. After ...
Latest News

September 29, 2023